Water intake and bladder cancer risk in Los Angeles County

International Journal of Cancer

Volumn 123, Issue 7, 2008, Pages 1649-1656

  Jiang, Xuejuan ^a,d   Castelao, Jose E ^a,b   Groshen, Susan ^a   Cortessis, Victoria K ^a   Shibata, Darryl K ^c   Conti, David V ^a   Gago Dominguez, Manuela ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Bladder cancer; Fluid; Los Angeles; Urination; Water

Indexed keywords

ALCOHOL; SODIUM CARBONATE;

ADULT; ARTICLE; BLADDER CANCER; CACAO; CANCER RISK; COFFEE; CONTROLLED STUDY; FEMALE; FLUID INTAKE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICTURITION; MILK; NOCTURIA; PRIORITY JOURNAL; RISK REDUCTION; TEA; UNITED STATES; URINARY FREQUENCY; BLADDER TUMOR; CASE CONTROL STUDY; DRINKING; RISK FACTOR; WATER SUPPLY;

CASE-CONTROL STUDIES; DRINKING; FEMALE; HUMANS; LOS ANGELES; MALE; RISK FACTORS; URINARY BLADDER NEOPLASMS; WATER SUPPLY;

EID: 50549100228     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23711     Document Type: Article

References (57)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Yu MC, Ross RK. Bladder cancer: epidemiology. In: Bertino JR, ed. Encyclopedia of cancer, 2nd edn., vol. 1. San Diego: Academic Press, 2002;215-21.
3. Jones PA, Ross RK. Prevention of bladder cancer. N Engl J Med 1999;340:1424-6.
4. Michaud DS, Spiegelman D, Clinton SK, Rimm EB, Curhan GC, Willett WC, Giovannucci EL. Fluid intake and the risk of bladder cancer in men. N Engl J Med 1999;340:1390-7.
5. Villanueva CM, Cantor KP, King WD, Jaakkola JJ, Cordier S, Lynch CF, Porru S, Kogevinas M. Total and specific fluid consumption as determinants of bladder cancer risk. Int J Cancer 2006;118:2040-7.
6. Castelao JE, Yuan JM, Skipper PL, Tannenbaum SR, GagoDominguez M, Crowder JS, Ross RK, Yu MC. Gender- and smoking-related bladder cancer risk. J Natl Cancer Inst 2001;93:538-45.
7. Bernstein L, Ross RK. Cancer in Los Angeles countyed. Los Angeles, CA: University of Southern California, 1991.
8. Castelao JE, Yuan JM, Gago-Dominguez M, Yu MC, Ross RK. Non-steroidal anti-inflammatory drugs and bladder cancer prevention. Br J Cancer 2000;82:1364-9.
9. Castelao JE, Yuan JM, Gago-Dominguez M, Skipper PL, Tannenbaum SR, Chan KK, Watson MA, Bell DA, Coetzee GA, Ross RK, Yu MC. Carotenoids/vitamin C and smoking-related bladder cancer. Int J Cancer 2004;110:417-23.
10. Jiang X, Castelao JE, Groshen S, Cortessis VK, Ross RK, Conti DV, Gago-Dominguez M. Alcohol consumption and risk of bladder cancer in Los Angeles County. Int J Cancer 2007;121:839-45.
11. van Kerrebroeck P, Abrams P, Chaikin D, Donovan J, Fonda D, Jackson S, Jennum P, Johnson T, Lose G, Mattiasson A, Robertson G, Weiss J. The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:179-83.
12. Mommsen S, Aagaard J, Sell A. An epidemiological case-control study of bladder cancer in males from a predominantly rural district. Eur J Cancer Clin Oncol 1982;18:1205-10.
13. Mommsen S, Sell A. Prostatic hypertrophy and venereal disease as possible risk factors in the development of bladder cancer. Urol Res 1983;11:49-52.
14. Wu JM, Williams KS, Hundley AF, Jannelli ML, Visco AG. Microscopic hematuria as a predictive factor for detecting bladder cancer at cystoscopy in women with irritative voiding symptoms. Am J Obstet Gynecol 2006;194:1423-6.
15. Zeegers MP, Kellen E, Buntinx F, van den Brandt PA. The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol 2004;21:392-401.
16. Altieri A, La Vecchia C, Negri E. Fluid intake and risk of bladder and other cancers. Eur J Clin Nutr 2003;57 (Suppl 2):S59-S68.
17. Braver DJ, Modan M. Chetrit A. Lusky A, Braf Z. Drinking, micturition habits, and urine concentration as potential risk factors in urinary bladder cancer. J Natl Cancer Inst 1987;78:437-40.
18. Oyasu R, Hopp ML. The etiology of cancer of the bladder. Surg Gynecol Obstet 1974;138:97-108.
19. Melicow MM. Tumors of the bladder: a multifaceted problem. J Urol 1974;112:467-78.
20. Radosavljevic V. Fluid balance, diet and bladder cancer occurrence. Eur J Cancer Prev 2004;13:151.
21. Radosavljevic V, Jankovic S, Marinkovic J, Djokic M. Fluid intake and bladder cancer. A case control study. Neoplasma 2003;50:234-8.
22. Kadlubar FF, Dooley KL, Teitel CH, Roberts DW, Benson RW, Butler MA, Bailey JR, Young JF, Skipper PW, Tannenbaum SR. Frequency of urination and its effects on metabolism, pharmacokinetics, blood hemoglobin adduct formation, and liver and urinary bladder DNA adduct levels in beagle dogs given the carcinogen 4-aminobiphenyl. Cancer Res 1991;51:4371-7.
23. Bois FY, Krowech G, Zeise L. Modeling human interindividual variability in metabolism and risk: the example of 4-aminobiphenyl. Risk Anal 1995;15:205-213.
24. Michaud DS, Kogevinas M, Cantor KP, Villanueva CM, Garcia-Closas M, Rothman N, Malats N, Real FX, Serra C, Garcia-Closas R, Tardon A, Carrato A, et al. Total fluid and water consumption and the joint effect of exposure to disinfection by-products on risk of bladder cancer. Environ Health Perspect 2007;115:1569-72.
25. IARC. Coffee, tea, mate, methylxanthines and methylglyoxal. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 27 February to 6 March 1990. IARC Monogr Eval Carcinog Risks Hum 1991;51:1-513.
26. Zierler S, Feingold L, Danley RA, Craun G. Bladder cancer in Massachusetts related to chlorinated and chloraminated drinking water: a case-control study. Arch Environ Health 1988;43:195-200.
27. Wu MM, Kuo TL, Hwang YH, Chen CJ. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol 1989;130:1123-32.
28. Morales Suarez-Varela M. Llopis Gonzalez A, Tejerizo Perez ML, Ferrandiz Ferragud J. Concentration of nitrates in drinking water and its relationship with bladder cancer. J. Environ Pathol Toxicol Oncol 1993;12:229-36.
29. Allam MF. Fluid intake and urinary bladder cancer. Eur J Cancer Prev 2005;14:77-8.
30. Zeegers MP, Dorant E. Goldbohm RA, van den Brandt PA. Are coffee, tea, and total fluid consumption associated with bladder cancer risk? Results from the Netherlands Cohort Study. Cancer Causes Control 2001;12:231-8.
31. Wilkens LR, Kadir MM, Kolonel LN, Nomura AM, Hankin JH. Risk factors for lower urinary tract cancer: the role of total fluid consumption, nitrites and nitrosamines. and selected foods. Cancer Epidemiol Biomarkers Prev 1996;5:161-6.
32. Bruemmer B, White E, Vaughan TL, Cheney CL. Fluid intake and the incidence of bladder cancer among middle-aged men and women in a three-county area of western Washington. Nutr Cancer 1997;29:163-8.
33. Pohlabeln H, Jockel KH, Bolm-Audorff U. Non-occupational risk factors for cancer of the lower urinary tract in Germany. Eur J Epidemiol 1999;15:411-19.
34. Geoffroy-Perez B, Cordier S. Fluid consumption and the risk of bladder cancer: results of a multicenter case-control study. Int J Cancer 2001;93:880-7.
35. Cantor KP, Lynch CF, Hildesheim ME, Dosemeci M, Lubin J, Alavanja M, Craun G. Drinking water source and chlorination byproducts. I. Risk of bladder cancer. Epidemiology 1998;9:21-8.
36. Yoshimura Y, Schmidt F, Constantinou CE. Gender specificity of tolterodine on micturition and the diurnal variation of urine production of the conscious rat. BJU Int 2000;86:879-85.
37. Claybaugh JR, Sato AK, Crosswhite LK, Hassell LH. Effects of time of day, gender, and menstrual cycle phase on the human response to a water load. Am J Physiol Regul Integr Comp Physiol 2000;279:R966-R973.
38. van Haarst EP, Heideweg EA, Newling DW, Schlatmann TJ. The 24-h frequency-volume chart in adults reporting no voiding complaints: defining reference values and analysing variables. BJU Int 2004;93:1257-61.
39. Burgio KL, Engel BT, Locher JL. Normative patterns of diurnal urination across 6 age decades. J Urol 1991;145:728-31.
40. Mueller E, Latini J, Lux M, Stablein U, Brubaker L, Kreder K, Fitzgerald MP. Gender differences in 24-hour urinary diaries of asymptomatic North American adults. J Urol 2005;173:490-2.
41. Longhurst PA, Kauer J, Leggett RE, Levin RM. The influence of ovariectomy and estradiol replacement on urinary bladder function in rats. J Urol 1992;148:915-19.
42. Hatano T, Ogawa K, Kanda K, Seo H, Matsui N. Effect of ovarian steroids on cyclic adenosine 3′:5′-monophosphate production stimulated by arginine vasopressin in rat renal monolayer cultured cells. Endocrinol Jpn 1988;35:267-74.
43. Rembratt A, Norgaard JP, Andersson KE. Differences between nocturics and non-nocturics in voiding patterns: an analysis of frequency-volume charts from community-dwelling elderly. BJU Int 2003;9145-50.
44. Bing MH, Moller LA. Jennum P, Mortensen S, Lose G. Pathophysiological aspects of nocturia in a Danish population of men and women age 60 to 80 years. J Urol 2007;178:552-7.
45. Matthiesen TB, Rittig S, Mortensen JT, Djurhuus JC. Nocturia and polyuria in men referred with lower urinary tract symptoms, assessed using a 7-day frequency-volume chart. BJU Int 1999;83:1017-22.
46. Lundgren R. Nocturia: a new perspective on an old symptom. Scand J Uvol Nephrol 2004;38:112-16.
47. Thorpe A, Neal D. Benign prostatic hyperplasia. Lancet 2003;361:1359-67.
48. Holroyd-Leduc JM, Straus SE. Management of urinary incontinence in women: scientific review. JAMA 2004;291:986-95.
49. Tubaro A, Palleschi G. Overactive bladder: epidemiology and social impact. Curr Opin Obstet Gynecol 2005;17:507-11.
50. West DB, Wehberg KE, Kieswetter K, Granger JP. Blunted natriuretic response to an acute sodium load in obese hypertensive dogs. Hypertension 1992;19:196-1100.
51. Tripathi A, Folsom AR, Anderson KE. Risk factors for urinary bladder carcinoma in postmenopausal women. The Iowa Women's Health Study. Cancer 2002;95:2316-23.
52. Bankir L, Bardoux P, Ahloulay M. Vasopressin and diabetes mellitus. Nephron 2001;87:8-18.
53. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 2004;159:1160-7.
54. Ng Y, Husain I, Waterfall N. Diabetes mellitus and bladder cancer - an epidemiological relationship? Pathol Oncol Res 2003;9:30-1.
55. Kravchick S, Gal R, Cytron S, Peled R, Weissman Y, Mukamel E, Koren R. Increased incidence of diabetes mellitus in the patients with transitional cell carcinoma of urinary bladder. Pathol Oncol Res 2001;7:56-9.
56. Risch HA, Burch JD, Miller AB, Hill GB, Steele R, Howe GR. Dietary factors and the incidence of cancer of the urinary bladder. Am J Epidemiol 1988;127:1179-91.
57. Larsson SC, Orsini N, Brismar K, Wolk A. Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia 2006;49:2819-23.